Table 4.
Secondary prophylaxis after toxoplasmosis disease
Intention | Intervention | SoR | QoE | Comments | Ref |
---|---|---|---|---|---|
To prevent relapse of CNS toxoplasmosis | Pyrimethamine (25 mg/day)a + sulfadiazine (orally, 30 mg/kg/d) | A | IIt | Minimum duration for 3 months, many cases longer | [204, 206] |
Pyrimethamine (25 mg/d)a + clindamycin (intravenously, 1200 mg/d) | B | IIt | [255–257] | ||
Atovaquone 750 mg qid | B | IIt | In patients intolerant to conventional toxoplasmic encephalitis therapies | [206] |
aShould be combined with folinic acid